Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Illumina, Inc.    ILMN

Delayed Quote. Delayed  - 07/22 10:00:00 pm
150.76 USD   -0.36%
07/12 ILLUMINA : to Announce Second Quarter 2016 Financial Results on Tues..
07/11 ENZO BIOCHEM : Life Sciences Unit Reaches $21 Million Patent Infring..
07/07 ILLUMINA : Applauds FDA’s Issuance of Draft Guidances to Advan..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

Illumina : to Announce Second Quarter 2016 Financial Results on Tuesday, July 26, 2016

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/21/2016 | 07:32pm CEST

By a News Reporter-Staff News Editor at Biotech Business Week -- Illumina, Inc. (NASDAQ:ILMN) announced that it will issue results for second quarter 2016 following the close of market on Tuesday, July 26, 2016 (see also Biotechnology Companies).

On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time), Francis deSouza, President and Chief Executive Officer, and Marc Stapley, Executive Vice President, Chief Administrative Officer, and Chief Financial Officer, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results. Conference Call Details The conference call will begin at 2:00 pm Pacific Time (5:00 pm Eastern Time) on Tuesday, July 26, 2016. Interested parties may listen to the call by dialing 844.647.5490 (passcode: 45971090), or if outside North America by dialing +1.615.247.0295 (passcode: 45971090). Individuals may access the live teleconference in the Investor Relations section of Illumina's web site under the "company" tab at www.illumina.com.

A replay of the conference call will be available from 5:00 pm Pacific Time (8:00 pm Eastern Time) on July 26, 2016 through August 2, 2016 by dialing 855.859.2056 (passcode: 45971090), or if outside North America by dialing +1.404.537.3406 (passcode: 45971090). About Illumina Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit www.illumina.com and follow @illumina. View source version on businesswire.com: http://www.businesswire.com/news/home/20160712005519/en/

Keywords for this news article include: Illumina Inc., Investment and Finance, Biotechnology Companies.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2016, NewsRx LLC

(c) 2016 NewsRx LLC, source Health Newsletters

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ILLUMINA, INC.
07/21 ILLUMINA : to Announce Second Quarter 2016 Financial Results on Tuesday, July 26..
07/15 ILLUMINA : Combine Solicitation - DNA sequencing reagents for the Illumina seque..
07/15 ILLUMINA : Amendment to Combined Synopsis/Solicitation - MiSeq and MiniSeq Syste..
07/15 ILLUMINA : Combine Solicitation - MiSeq and MiniSeq Systems Reagents
07/14 ILLUMINA : Presolicitation Notice - Illumina iSelect Custom DNA Beadchip and MiS..
07/12 ILLUMINA : to Announce Second Quarter 2016 Financial Results on Tuesday, July 26..
07/11 ENZO BIOCHEM : Life Sciences Unit Reaches $21 Million Patent Infringement Settle..
07/07 NATERA : and Illumina Extend Supply Agreement, Broaden Existing Partnership to I..
07/07 Merck KGaA, Darmstadt, Germany Welcomes ZEISS and Hamilton Thorne as New Memb..
07/07 ILLUMINA : TSRI scientists reveal single-neuron gene landscape of the human brai..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
07/21 MCKESSON : Theranos hires executives in regulatory, compliance push
07/21DJTheranos Hires Compliance, Regulatory Executives
07/20DJSt. Jude Medical Logs Double-Digit Sales Growth
07/19DJINTUITIVE SURGICAL : Tops Expectations
07/19DJINTUITIVE SURGICAL : Tops Expectations
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
07/19 Pacific Biosciences Looking More Interesting Once Again
07/18 Illumina - DNA Sequencing Applications And The Holy GRAIL
07/12 Exact Sciences up 7% on rumored interest from Illumina
07/08 Healthcare ratings roundup
07/07 Illumina to pay Enzo Biochem $21M to settle patent fight
Advertisement
Financials ($)
Sales 2016 2 476 M
EBIT 2016 691 M
Net income 2016 435 M
Finance 2016 597 M
Yield 2016 -
P/E ratio 2016 50,79
P/E ratio 2017 41,64
EV / Sales 2016 8,72x
EV / Sales 2017 7,48x
Capitalization 22 192 M
More Financials
Chart ILLUMINA, INC.
Duration : Period :
Illumina, Inc. Technical Analysis Chart | ILMN | US4523271090 | 4-Traders
Full-screen chart
Technical analysis trends ILLUMINA, INC.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 23
Average target price 154 $
Spread / Average Target 1,8%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Francis A. deSouza President, Chief Executive Officer & Director
Jay T. Flatley Executive Chairman
Robert P. Ragusa Senior Vice President-Global Quality & Operations
Marc A. Stapley EVP, Chief Financial & Administrative Officer
Mostafa Ronaghi Chief Technology Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ILLUMINA, INC.-21.46%22 192
THERMO FISHER SCIENTIF..10.60%61 738
BOSTON SCIENTIFIC CORP..29.72%32 456
INTUITIVE SURGICAL, IN..26.22%26 536
PHILIPS0.96%24 759
EDWARDS LIFESCIENCES C..34.53%22 500
More Results